期刊文献+

流感疫苗神经氨酸酶的分离纯化方法建立及其参考品制备 被引量:3

Isolation and purification of neuraminidase from influenza vaccine and reference substance preparation
原文传递
导出
摘要 目的建立流感疫苗神经氨酸酶分离纯化方法,并制备神经氨酸酶定量检测参考品。方法制备对神经氨酸酶具有特异亲和力的功能化磁粒,建立基于该磁粒分离纯化神经氨酸酶的方法,优化分离纯化条件,对分离纯化的神经氨酸酶进行纯度分析和特异性验证,并进行酶活性测定和蛋白质定量。结果成功制备4-氨基苯草氨酸修饰的功能磁粒,建立基于该磁粒分离纯化神经氨酸酶方法,分离纯化神经氨酸酶纯度为98.7%,从H1N1、H3N2、B/Victoria和B/Yamagate 4种疫苗单价原液分离纯化的神经氨酸酶蛋白质浓度分别为71.50、100.58、64.11和37.68μg/ml,且均保留酶活性。结论建立了分离纯化流感病毒神经氨酸酶方法并制备了相应参考品。 Objective To establish a method for isolation and purification of neuraminidase from influenza vaccine and to prepare reference substance for quantitative detection of neuraminidase.Methods Functional magnetic particles with specific affinity for neuraminidase were prepared.The method for separation and purification of neuraminidase was established based on the magnetic particles.The separation and purification conditions were optimized.The purity of neuraminidase was analyzed and the specificity was verified.The enzyme activity was determined and the protein was quantified.Results The functional magnetic particles modified with 4-aminophenanthroline were successfully prepared and the method for isolation and purification of neuraminidase based on the magnetic particles was established.The purity of neuraminidase was 98.7%.The concentrations of neuraminidase isolated and purified from the monovalent stock solution of H1N1,H3N2,B/Victoria and B/Yamagate vaccines were 71.50,100.58,64.11 and 37.68μg/ml,respectively,and the enzyme activity remained.Conclusions The method for isolation and purification of influenza virus neuraminidase was established and the corresponding reference substance was prepared.
作者 邓涛 张家友 杨晓明 Deng Tao;Zhang Jiayou;Yang Xiaoming(The Second Research Department of Viral Vaccine,Wuhan Institute of Biological Products Co.,Ltd.,Wuhan 430207,China;National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China;China National Biotech Group Co.,Ltd.,Beijing 100024,China)
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2021年第11期875-879,共5页 Chinese Journal of Microbiology and Immunology
基金 国家科技重大专项"重大新药创制"(2016ZX09106003-008,2015ZX09102021) 湖北省技术创新专项重大项目(2017ACA078)。
关键词 神经氨酸酶 流感疫苗 分离纯化 参考品 Neuraminidase Influenza vaccine Isolation and purification Reference substance
  • 相关文献

参考文献2

二级参考文献7

  • 1Takahashi Y. Hasegawa tt, Hara Y, et al. Protective immunity afforded by inactivated H5NI (NIBRG-14) vaccine requires anti- bodies against both ]lemagglutinin and nemmninidase ill mice[ J]. .1 Infect Dis, 2009,199( 11 ) :1629-I637.
  • 2Cate TR, Ilayford Y, Ninn D, et al. A high dosage influenza vae- eine indueed significantly more neuraminidase antibody than stand- ard vaccine among ehlerly subjects[ J]. Vaccine, 2010, 28 (9) : 2076-2079.
  • 3Graw~l C, Li C, Wang J, e! al. Qualitative and quantitative analy- ses of virtually all subtypes of influenza A and B viral neuramini- dases using amibodi~,s targeting the universally conserved se- quences ~ J ]. Vaccine, 2010,28 ( 36 ) :5774-5784.
  • 41,i C, Shao M, Cui X, et al. Application of deglyeosylation and e- lectrophoresis to the quantification of influenza viral hemagglutinins theilitating the production of 2009 pandemic ilffluenza ( HI NI ) wtccines at muhiple manufaeturing sites in China[ J ]. 'Biologieals, 2010, 38( 2 ) :284-289.
  • 5邵铭,李娟,宋颖丽,崔晓雨,袁力勇,方捍华,李长贵,李凤祥,王军志.流感疫苗血凝素含量测定替代方法的建立及验证[J].中国生物制品学杂志,2010,23(7):770-773. 被引量:5
  • 6邵铭,袁力勇,刘书珍,方捍华,李凤祥,胡忠玉,李长贵,王军志.流感疫苗血凝素含量测定替代方法在甲型H1N1流感疫苗研发中的应用[J].药物分析杂志,2012,32(2):353-355. 被引量:1
  • 7曹鸿鹏,陶佩珍,杜冠华.流感病毒神经氨酸酶抑制剂筛选模型的建立和应用[J].药学学报,2002,37(12):930-933. 被引量:32

共引文献2

同被引文献6

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部